• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

快速心房颤动中地高辛静脉输注与大剂量注射:血清水平与反应之间的关系

Digoxin infusion versus bolus injection in rapid atrial fibrillation: relation between serum level and response.

作者信息

Smit A J, Scaf A H, van Essen L H, Lie K I, Wesseling H

机构信息

Department of Internal Medicine, University of Groningen, The Netherlands.

出版信息

Eur J Clin Pharmacol. 1990;38(4):335-41. doi: 10.1007/BF00315571.

DOI:10.1007/BF00315571
PMID:2344857
Abstract

Using available data on time-concentration and time-effect relationships in normal persons the results of infusion of digoxin in various time periods were simulated and compared with administration of digoxin by bolus injections, using a three-compartment pharmacokinetic model to which a separate small side-effect compartment was subsequently added. The validity of the simulations was tested in 11 patients with rapid atrial fibrillation. Serum digoxin concentrations, ventricular rate and side effects were monitored in a double-blind study comparing an infusion of 1.5 mg digoxin over 6 h with administration of three bolus injections of 0.5 mg digoxin 8 h apart. In agreement with the predictions of the model, the maximal fall in ventricular rate was reached after 8-9 h in the infusion group and after 19-20 h in the bolus injection group, without any detectable difference in side effects. There were certain discrepancies between the results of the clinical study and the predictions of the model, e.g. in serum digoxin concentrations, perhaps due to impaired clearance in the patients. However, it is concluded that the tested model is valid in elderly patients with rapid atrial fibrillation.

摘要

利用正常人时间-浓度和时间-效应关系的现有数据,采用三室药代动力学模型(随后增加了一个单独的小副作用室)模拟了不同时间段输注地高辛的结果,并与静脉推注地高辛的结果进行了比较。在11例快速心房颤动患者中对模拟的有效性进行了测试。在一项双盲研究中,监测了血清地高辛浓度、心室率和副作用,该研究比较了6小时内输注1.5毫克地高辛与间隔8小时静脉推注3次0.5毫克地高辛的情况。与模型预测一致,输注组在8-9小时后心室率降至最大,静脉推注组在19-20小时后心室率降至最大,副作用无任何可检测到的差异。临床研究结果与模型预测之间存在某些差异,例如血清地高辛浓度方面,可能是由于患者清除率受损所致。然而,得出的结论是,所测试的模型在老年快速心房颤动患者中是有效的。

相似文献

1
Digoxin infusion versus bolus injection in rapid atrial fibrillation: relation between serum level and response.快速心房颤动中地高辛静脉输注与大剂量注射:血清水平与反应之间的关系
Eur J Clin Pharmacol. 1990;38(4):335-41. doi: 10.1007/BF00315571.
2
Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.急性心房颤动患者静脉注射地高辛:基于急性心房颤动地高辛试验的群体药代动力学/药效学分析
Eur J Clin Pharmacol. 2003 Mar;58(11):747-55. doi: 10.1007/s00228-002-0553-3. Epub 2003 Feb 19.
3
Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate.高剂量静脉推注胺碘酮对房颤伴快速心室率患者的影响。
Int J Cardiol. 2006 Jun 7;110(1):27-32. doi: 10.1016/j.ijcard.2005.06.048. Epub 2005 Jul 19.
4
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study.采用静脉注射胺碘酮的个体化给药方案对近期发作的心房颤动和心房扑动进行急性治疗。一项随机、地高辛对照研究。
Eur Heart J. 1995 Apr;16(4):521-8. doi: 10.1093/oxfordjournals.eurheartj.a060945.
5
Effects of digoxin on electrocardiogram in patients with acute atrial fibrillation--a randomized, placebo-controlled study. Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group.地高辛对急性房颤患者心电图的影响——一项随机、安慰剂对照研究。急性房颤洋地黄治疗(DAAF)试验组。
Clin Cardiol. 1999 Feb;22(2):96-102. doi: 10.1002/clc.4960220208.
6
Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.心房颤动急性心率控制期间的左心室功能:心率及所用药物的重要性。
J Cardiovasc Pharmacol Ther. 2003 Mar;8(1):17-24. doi: 10.1177/107424840300800i104.
7
Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.心房颤动和心房扑动的急诊处理:静脉注射地尔硫䓬与静脉注射地高辛的比较
Ann Emerg Med. 1997 Jan;29(1):135-40. doi: 10.1016/s0196-0644(97)70319-6.
8
Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.
Am J Cardiol. 1998 Sep 1;82(5):584-8. doi: 10.1016/s0002-9149(98)00412-3.
9
A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study.一项关于持续性静脉输注地尔硫䓬用于心房颤动和心房扑动时24小时心率控制的安慰剂对照试验:一项多中心研究。
J Am Coll Cardiol. 1991 Oct;18(4):891-7. doi: 10.1016/0735-1097(91)90743-s.
10
Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.临床决策分析建模:心房颤动或心房扑动时心室率的短期控制——地高辛与地尔硫䓬对比
Pharmacotherapy. 1994 Jul-Aug;14(4):446-51.

引用本文的文献

1
Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.急性心房颤动患者静脉注射地高辛:基于急性心房颤动地高辛试验的群体药代动力学/药效学分析
Eur J Clin Pharmacol. 2003 Mar;58(11):747-55. doi: 10.1007/s00228-002-0553-3. Epub 2003 Feb 19.
2
Effects of digoxin on electrocardiogram in patients with acute atrial fibrillation--a randomized, placebo-controlled study. Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group.地高辛对急性房颤患者心电图的影响——一项随机、安慰剂对照研究。急性房颤洋地黄治疗(DAAF)试验组。
Clin Cardiol. 1999 Feb;22(2):96-102. doi: 10.1002/clc.4960220208.

本文引用的文献

1
Clinical course of acute atrial fibrillation treated with rapid digitalization.快速洋地黄化治疗急性心房颤动的临床病程
Am Heart J. 1983 Feb;105(2):223-7. doi: 10.1016/0002-8703(83)90517-3.
2
Rapid achievement of a serum concentration plateau of digoxin through controlled infusion.
Eur J Clin Pharmacol. 1983;25(4):455-7. doi: 10.1007/BF00542110.
3
[Ophthalmological aspects of digitoxin poisoning].[洋地黄毒苷中毒的眼科表现]
Ned Tijdschr Geneeskd. 1969 Oct 4;113(40):1735-7.
4
Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.药代动力学在药物剂量调整中的作用。I. 地高辛的药理效应动力学及表观分布容积。
J Clin Pharmacol New Drugs. 1973 Apr;13(4):127-41. doi: 10.1002/j.1552-4604.1973.tb00074.x.
5
Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.地高辛的药代动力学:人体二室模型与三室模型的比较
J Pharmacokinet Biopharm. 1974 Aug;2(4):299-312. doi: 10.1007/BF01061404.
6
Statistical estimations in pharmacokinetics.药物动力学中的统计学估计
J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504.
7
Pharmacokinetic analyses with RUGFIT: an interactive pharmacokinetic computer program.使用RUGFIT进行药代动力学分析:一个交互式药代动力学计算机程序。
Biopharm Drug Dispos. 1988 Sep-Oct;9(5):415-46. doi: 10.1002/bod.2510090502.
8
Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.维库溴铵和泮库溴铵在麻醉患者中的比较药代动力学和药效动力学
Anesth Analg. 1986 Mar;65(3):233-9.
9
Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.地高辛药代动力学:多房室分析及其临床意义。
Br J Clin Pharmacol. 1976 Apr;3(2):221-9. doi: 10.1111/j.1365-2125.1976.tb00596.x.
10
Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.
J Pharmacokinet Biopharm. 1979 Feb;7(1):47-61. doi: 10.1007/BF01059440.